Promoting the Universal Medication Schedule Via Mobile and EHR Technologies
Completed · Not applicable
Conditions studied: Type 2 Diabetes
In brief
The purpose of this study test the effectiveness of the Universal Medication Schedule (UMS), which was designed as a strategy to standardize and simplify medication instructions to support safe and effective prescription drug use among diabetic.
Key facts
- Study ID
- NCT02248857
- Run by
- Northwestern University
- People needed
- 452
- Starts
- 2014-12-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2019-03-25
Who can join
Age: 30 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- diagnosis of type II diabetes
- age 30 or older
- taking 3 or more prescription medications for chronic conditions
- English or Spanish speaking
You may not qualify if…
- self-reported severe, uncorrectable vision
- hearing impairment
- cognitive impairment
- not responsible for administering his/her own medications
- not able to receive text messages on their cell phone
Where it is running
- Northwestern University — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.